Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-06-20
1991-10-01
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514616, 564153, 564157, 530331, A61K 3121
Patent
active
050533932
ABSTRACT:
N-[8-[(Aminoiminomethyl)amino]-1-oxooctyl]-N-L-.alpha.-aspartyl-L-phenylani ne is disclosed as a highly potent inhibitor of platelet aggregation.
REFERENCES:
patent: 4051141 (1977-09-01), Castaigne
patent: 4127580 (1978-11-01), Braye
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4614517 (1986-09-01), Rouslahti et al.
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4683291 (1987-07-01), Zimmerman et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4879313 (1989-11-01), Tjoeng et al.
Kloczewiak et al., Biochem., 23, 1767-1774 (1984).
Plow et al., Proc. Natl. Acad. Sci., 82, 8057-8061 (1984).
Ruggerri et al., Ibid., 83, 5708-5712 (1986).
Ginsberg et al., J. Biol. Chem., 260(7), 3931-3936 (1985).
Haverstick et al., Blood, 66(4), 946-952 (1985).
Adams Steven P.
Feigen Larry P.
Tjoeng Foe S.
G. D. Searle & Co.
Ivy C. Warren
Meyer Scott J.
Monsanto Company
Northington-Davis Zinna
LandOfFree
Novel platelet-aggregation inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel platelet-aggregation inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel platelet-aggregation inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755076